(Reuters) – Bharat Biotech’s COVID-19 vaccine Covaxin has gained approval for emergency use in children aged 12 to 18, the Indian company said on Twitter https://bit.ly/3Em588U.
The tweet came minutes after Indian Prime Minister Narendra Modi said in an address to the nation that 15-18 year olds would start receiving COVID-19 vaccinations from Jan. 3.
(Reporting by Sabahatjahan Contractor in Bengaluru; Editing by Rupam Jain and David Goodman)
